Works matching AU Tong, Hongyan

Results: 106

Blood biomarkers are altered in elderly hematological patients exhibiting a mosaic loss of the Y chromosome in bone marrow cells.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14584-0

By:

Liu, Lin;
You, Liangshun;
Xu, Huan;
Wang, Lu;
Zhao, Shuqi;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.

Published in:

European Journal of Haematology, 2008, v. 81, n. 4, p. 259, doi. 10.1111/j.1600-0609.2008.01116.x

By:

Hongyan Tong;
Yanling Ren;
Fengjuan Zhang;
Jie Jin

Publication type:

Article

Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.

Published in:

2009

By:

Tong, Hongyan;
Ren, Yanling;
Qian, Wenbin;
Xiao, Feng;
Mai, Wenyuan;
Meng, Haitao;
Jin, Jie

Publication type:

journal article

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3‐ITD.

Published in:

Molecular Oncology, 2023, v. 17, n. 7, p. 1402, doi. 10.1002/1878-0261.13368

By:

Qian, Yu;
Zhang, Xiang;
Mao, Shihui;
Wei, Wenwen;
Lin, Xiangjie;
Ling, Qing;
Ye, Wenle;
Li, Fenglin;
Pan, Jiajia;
Zhou, Yutong;
Zhao, Yanchun;
Huang, Xin;
Huang, Jiansong;
Tong, Hongyan;
Sun, Jie;
Jin, Jie

Publication type:

Article

Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic prognostic biomarkers for secondary central nervous system lymphoma.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13195-5

By:

Gu, Jiayan;
Huang, Xin;
Zhang, Yi;
Bao, Chenhui;
Zhou, Ziyang;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes.

Published in:

Cancer Science, 2020, v. 111, n. 2, p. 580, doi. 10.1111/cas.14270

By:

Jiang, Lingxu;
Luo, Yingwan;
Zhu, Shuanghong;
Wang, Lu;
Ma, Liya;
Zhang, Hua;
Shen, Chuying;
Yang, Wenli;
Ren, Yanling;
Zhou, Xinping;
Mei, Chen;
Ye, Li;
Xu, Weilai;
Yang, Haiyang;
Lu, Chenxi;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

Published in:

American Journal of Hematology, 2024, v. 99, n. 9, p. 1768, doi. 10.1002/ajh.27412

By:

Röth, Alexander;
He, Guangsheng;
Tong, Hongyan;
Lin, Zenghua;
Wang, Xiaoqin;
Chai‐Adisaksopha, Chatree;
Lee, Je‐Hwan;
Brodsky, Andres;
Hantaweepant, Chattree;
Dumagay, Teresita E.;
Demichelis‐Gómez, Roberta;
Rojnuckarin, Ponlapat;
Sun, Jing;
Höglund, Martin;
Jang, Jun Ho;
Gaya, Anna;
Silva, Fernando;
Obara, Naoshi;
Kelly, Richard J.;
Beveridge, Leigh

Publication type:

Article

Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.

Published in:

American Journal of Hematology, 2024, v. 99, n. 7, p. 1441, doi. 10.1002/ajh.27340

By:

Zhou, Ziyue;
Zhuo, Nanfang;
Zhou, Yile;
Sun, Caihong;
Yao, Yiyi;
Mao, Liping;
Zhang, Yi;
Hong, Qing;
Pan, Peifeng;
Tong, Hongyan;
Jin, Jie;
Wang, Huafeng

Publication type:

Article

Mutation landscape of normal karyotype myelodysplastic syndromes and their prognostic impact.

Published in:

American Journal of Hematology, 2024, v. 99, n. 2, p. E51, doi. 10.1002/ajh.27170

By:

Wang, Wei;
Zhang, Yudi;
Yang, Wenli;
Han, Yueyuan;
Jiang, Lingxu;
Liu, Xiaozhen;
Lang, Wei;
Luo, Yingwan;
Zhu, Shuanghong;
Zhou, Xinping;
Wang, Lu;
Ye, Li;
Ma, Liya;
Tong, Hongyan

Publication type:

Article

Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study.

Published in:

American Journal of Hematology, 2023, v. 98, n. 10, p. 1579, doi. 10.1002/ajh.27031

By:

Zhang, Yi;
Zhang, Qike;
Liu, Qingchi;
Dang, Huibing;
Gao, Sujun;
Wang, Wei;
Zhou, Hu;
Chen, Yuqing;
Ma, Liangming;
Wang, Jishi;
Yang, Haiping;
Lu, Binhua;
Yin, Hewen;
Wu, Liqing;
Suo, Shanshan;
Zhao, Qingwei;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single‐center pilot trial.

Published in:

American Journal of Hematology, 2023, v. 98, n. 5, p. E106, doi. 10.1002/ajh.26877

By:

Zhou, De;
Huang, Xianbo;
Xie, Mixue;
Zhu, Lixia;
Huang, Xin;
Li, Xueying;
Yang, Xiudi;
Li, Li;
Zhu, Jingjing;
Zheng, Xiaolong;
Sun, Jianai;
Zhao, Shuqi;
Yu, Wenjuan;
Xie, Wanzhuo;
Tong, Hongyan;
Jin, Jie;
Zhu, Honghu;
Ye, Xiujin

Publication type:

Article

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.

Published in:

Cancer Medicine, 2021, v. 10, n. 5, p. 1759, doi. 10.1002/cam4.3786

By:

Yan, Xuefen;
Wang, Lu;
Jiang, Lingxu;
Luo, Yingwan;
Lin, Peipei;
Yang, Wenli;
Ren, Yanling;
Ma, Liya;
Zhou, Xinping;
Mei, Chen;
Ye, Li;
Xu, Gaixiang;
Xu, Weilai;
Yang, Haiyang;
Lu, Chenxi;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study.

Published in:

Cancer Medicine, 2021, v. 10, n. 5, p. 1715, doi. 10.1002/cam4.3774

By:

Ma, Liya;
Jiang, Lingxu;
Yang, Wenli;
Luo, Yingwan;
Mei, Chen;
Zhou, Xinping;
Xu, Gaixiang;
Xu, Weilai;
Ye, Li;
Ren, Yanlin;
Lu, Chenxi;
Lin, Peipei;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.

Published in:

Cancer Medicine, 2020, v. 9, n. 15, p. 5327, doi. 10.1002/cam4.3079

By:

Qian, Jie‐Jing;
Hu, Xiaoxia;
Wang, Ying;
Zhang, Yi;
Du, Juan;
Yang, Min;
Tong, Hongyan;
Qian, Wen‐Bin;
Wei, Juying;
Yu, Wenjun;
Lou, Yin‐Jun;
Mao, Liping;
Tao Meng, Hai;
You, Liang‐Shun;
Wang, Libing;
Li, Xia;
Huang, Xin;
Cao, Li‐Hong;
Zhao, Jian‐Zhi;
Yan Yan, Xiao

Publication type:

Article

Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia.

Published in:

2024

By:

Yao, Yiyi;
Zhou, Yile;
Zhuo, Nanfang;
Xie, Wanzhuo;
Meng, Haitao;
Lou, Yinjun;
Mao, Liping;
Tong, Hongyan;
Qian, Jiejing;
Yang, Min;
Yu, Wenjuan;
Zhou, De;
Jin, Jie;
Wang, Huafeng

Publication type:

Letter

A new complex translocation t(9;17;15)(q31;q21;q22) in acute promyelocytic leukemia.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 9, p. 1545, doi. 10.1080/10428190903121822

By:

Tong, Hongyan;
Mei, Chen;
Wang, Huanping;
Chen, Zhimei;
Zhang, Jun;
Pan, Jinlan;
Jin, Jie

Publication type:

Article

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome.

Published in:

Leukemia & Lymphoma, 2008, v. 49, n. 1, p. 81, doi. 10.1080/10428190701713630

By:

Tong, Hongyan;
Ren, Yanling;
Liu, Hui;
Xiao, Feng;
Mai, Wenyuan;
Meng, Haitao;
Qian, Wenbin;
Huang, Jian;
Mao, Lingping;
Tong, Ying;
Wang, Lei;
Qian, Jiejing;
Jin, Jie

Publication type:

Article

Intestinal ulcers in a patient with myelodysplastic syndrome: a case report.

Published in:

2021

By:

Zhang, Xiaofen;
Jin, Meng;
Shen, Zhe;
Wan, Xingyong;
Li, Lan;
Zhang, Yuwei;
Zhou, Xinping;
Mei, Chen;
Tong, Hongyan;
Yu, Chaohui

Publication type:

journal article

P1313: LOW DOSE RITUXIMAB FOR PRE‐EMPTIVE TREATMENT OF EPSTEIN BARR VIRUS REACTIVATION AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE‐CENTER STUDY.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972140.02638.3e

By:

Mei, Chen;
Ren, Yanling;
Qian, Jiejin;
Tong, Hongyan

Publication type:

Article

P744: A REAL‐WORLD STUDY OF MULTIPLE‐CYCLE HYPOMETHYLATING AGENTS MONOTHERAPY IN MYELODYSPLASTIC SYNDROMES.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969880.82508.fa

By:

Liu, Xiaozhen;
Jiang, Huifang;
Ouyang, Guifang;
Zhou, Shujuan;
Huang, Jiang;
Zhang, Jin;
Zhao, Caifang;
Shao, Yanping;
Wu, Gongqiang;
Xiao, Xibin;
Mei, Chen;
Xu, Gaixiang;
MA, Liya;
Zhou, Xinping;
Ren, Yanling;
Tong, Hongyan

Publication type:

Article

P684: A MULTICENTER RETROSPECTIVE STUDY IN CHINA: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH CML‐CP TREATED WITH DIFFERENT TYROSINE KINASE INHIBITORS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969640.53011.8d

By:

Huang, Jian;
Zhang, Xinlu;
Feng, Weiying;
Qian, Honglan;
Yu, Chen;
Liu, Lirong;
Chen, Dan;
Zhu, Xiaoqiong;
Wang, Huafeng;
Yang, Xiudi;
Zhu, Jingjing;
Wu, Dijiong;
Zhou, Mei;
Lu, Ying;
Wang, Yi;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

P664: REAL‐WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969560.77193.a9

By:

Hu, Shiwei;
Wu, Dijiong;
Feng, Weiying;
Chen, Lili;
Cao, Lihong;
Zhu, Xiaoqiong;
Yang, Xiudi;
Zhu, Jingjing;
Wang, Huafeng;
Chen, Dan;
Tong, Hongyan;
Lu, Ying;
Qian, Honglan;
Wang, Yi;
Jin, Jie;
Huang, Jian

Publication type:

Article

P584: VENETOCLAX PLUS HOMOHARRINGTONINE‐BASED CHEMOTHERAPY AS FIRST‐LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE‐ARM, PHASE 2 TRIAL.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969240.88472.88

By:

Wang, Huafeng;
Yang, Min;
Tong, Hongyan;
Lou, Yinjun;
Zhu, Honghu;
Han, Yue;
Qian, Jiejin;
Mao, Liping;
Yang, Chunmei;
Lu, Ying;
Zhou, Xinping;
Shou, Lihong;
Meng, Haitao;
Zhou, De;
Yu, Wenjuan;
LI, LI;
Jin, Jie

Publication type:

Article

Prognostic effects of clinical parameters, genetic abnormalities, and subtypes in primary gastric diffuse large B-cell lymphoma: a cohort analysis of 146 patients.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3362, doi. 10.1080/10428194.2022.2126279

By:

Liu, Junqing;
Wei, Juying;
Jiang, Xue;
Yu, Wenjuan;
Tong, Hongyan;
Jin, Jie;
Yan, Senxiang;
Xu, Weilai

Publication type:

Article

Decitabine for myelodysplastic syndromes: dose comparison in a real world clinical setting.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 7, p. 1731, doi. 10.1080/10428194.2018.1546853

By:

Ren, Yanling;
Jiang, Huifang;
Shi, Fangjing;
Ye, Li;
Luo, Yingwan;
Zhou, Xinping;
Mei, Chen;
Ma, Liya;
Xu, Weilai;
Lin, Peipei;
Hu, Chao;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

The relation of SF3B1 mutation and intracellular iron in myelodysplastic syndrome with less than 5% bone marrow blasts.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 5, p. 1179, doi. 10.1080/10428194.2018.1520990

By:

Ma, Liya;
Luo, Yingwan;
Jiang, Lingxu;
Shen, Dan;
Li, Jianhu;
Xu, Weilai;
Mei, Chen;
Zhou, Xinping;
Ren, Yanlin;
Ye, Li;
Lu, Chenxi;
Jie, Jin;
Tong, Hongyan

Publication type:

Article

Clinical and biological characteristics of acute myeloid leukemia with 20–29% blasts: a retrospective single-center study.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 5, p. 1136, doi. 10.1080/10428194.2018.1515938

By:

Mei, Chen;
Ren, Yanling;
Zhou, Xinping;
Ye, Li;
Ma, Liya;
Luo, Yingwan;
Lin, Peipei;
Xu, Weilai;
Lu, Chenxi;
Yang, Haiyang;
Yu, Wenjuan;
Mao, Liping;
Wei, Juying;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1691, doi. 10.3109/10428194.2014.963074

By:

Jin, Jie;
Chen, Jian;
Suo, Shanshan;
Qian, Wenbin;
Meng, Haitao;
Mai, Wenyuan;
Tong, Hongyan;
Huang, Jian;
Yu, Wenjuan;
Wei, Juyin;
Lou, Yinjun

Publication type:

Article

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 1027, doi. 10.3109/10428194.2014.947606

By:

Lu, Shasha;
Xu, Yu;
Mu, Qitian;
Cao, Lihong;
Chen, Jian;
Zhu, Zhijuan;
Lou, Yinjun;
Meng, Haitao;
Qian, Wenbin;
Tong, Hongyan;
Mai, Wenyuan;
Huang, Jian;
Yu, Wenjuan;
Zhao, Xiaoying;
Jin, Jie

Publication type:

Article

Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 12, p. 2412, doi. 10.3109/10428194.2012.696637

By:

Tong, Hongyan;
Hu, Chao;
Zhuang, Zhengping;
Wang, Lijun;
Jin, Jie

Publication type:

Article

Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia

Published in:

Cancer (0008543X), 2023, v. 129, n. 10, p. 1523, doi. 10.1002/cncr.34710

By:

Xie, Mixue;
Shi, Ting;
Jiang, Qi;
Jia, Yunlu;
Zhou, De;
Tong, Hongyan;
Jin, Jie;
Zhu, Hong‐Hu

Publication type:

Article

Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1479, doi. 10.1111/bcp.16394

By:

Cosson, Valérie;
Fu, Rong;
Kulasekararaj, Austin;
Nishimura, Jun‐Ichi;
Panse, Jens;
Röth, Alexander;
Scheinberg, Phillip;
Tong, Hongyan;
Yoon, Sung‐Soo;
Beveridge, Leigh;
Gotanda, Keisuke;
Jaminion, Félix;
Henrich, Andrea;
Lundberg, Pontus;
Shi, Dayu;
Sreckovic, Sasha;
Zhang, Yuchen;
Zhang, Zilu;
Benkali, Khaled;
Buatois, Simon

Publication type:

Article

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-024-05995-x

By:

Wang, Wei;
Zhang, Yudi;
Yang, Wenli;
Liu, Xiaozhen;
Jiang, Lingxu;
Lang, Wei;
Luo, Yingwan;
Zhou, Xinping;
Wang, Lu;
Ye, Li;
Xu, Ying;
Ma, Liya;
Tong, Hongyan

Publication type:

Article

TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.

Published in:

Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 3, p. 172, doi. 10.1111/ajco.13316

By:

Ren, Yanling;
Wang, Jinghan;
Zhang, Hua;
Mei, Chen;
Ye, Li;
Luo, Yingwan;
Zhou, Xinping;
Zhu, Shuanghong;
Jiang, Lingxu;
Wang, Lu;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Moderate‐To‐Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Published in:

Hematological Oncology, 2025, v. 43, n. 2, p. 1, doi. 10.1002/hon.70043

By:

Xu, Gaixiang;
Ye, Xingnong;
Zhang, Yudi;
Wang, Wei;
Zhu, Shuanghong;
Li, Kongfei;
Zhou, Xinping;
Ma, Liya;
Ye, Li;
Mei, Chen;
Wang, Lu;
Ren, Yanling;
Jiang, Lingxu;
Huang, Jian;
Meng, Haitao;
Mai, Wenyuan;
Yu, Wenjuan;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis.

Published in:

Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3260

By:

Wang, Rong;
Zhang, Yi;
Chang, Jie;
Wang, Huafeng;
Lou, Yinjun;
Yang, Min;
Xu, Gaixiang;
Tong, Hongyan;
Xie, Wanzhuo;
Zhou, De;
Wei, Juying;
Mai, Wenyuan;
Ye, Xiujin;
Meng, Haitao;
Jin, Jie;
Zhu, Hong‐Hu

Publication type:

Article

15‐days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high‐risk myelodysplastic syndromes: A retrospective single‐center study.

Published in:

Hematological Oncology, 2023, v. 41, n. 3, p. 546, doi. 10.1002/hon.3112

By:

Mei, Chen;
Ye, Li;
Ren, Yanling;
Zhou, Xinping;
Ma, Liya;
Xu, Gaixiang;
Xu, Weilai;
Lu, Chenxi;
Yang, Haiyang;
Luo, Yingwan;
Jiang, Lingxu;
Lang, Wei;
Zhu, HongHu;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 159, doi. 10.1002/hon.3099

By:

Ren, Yanling;
Lang, Wei;
Mei, Chen;
Luo, Yingwan;
Ye, Li;
Wang, Lu;
Zhou, Xinping;
Xu, Gaixiang;
Ma, Liya;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial.

Published in:

Hematological Oncology, 2020, v. 38, n. 4, p. 531, doi. 10.1002/hon.2755

By:

Zhou, Xinping;
Mei, Chen;
Zhang, Jin;
Lu, Ying;
Lan, Jianping;
Lin, Shengyun;
Zhang, Yuefeng;
Kuang, Yuemin;
Ren, Yanling;
Ma, Liya;
Wei, Juying;
Ye, Li;
Xu, Weilai;
Li, Kongfei;
Lu, Chenxi;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.

Published in:

2018

By:

Lou, Yinjun;
Lu, Ying;
Zhu, Zhijuan;
Ma, Yafang;
Suo, Shanshan;
Wang, Yungui;
Chen, Dong;
Tong, Hongyan;
Qian, Wenbin;
Meng, Haitao;
Mai, Wenyuan;
Yu, Wenjun;
Xu, Weilai;
Wang, Lei;
Mao, Liping;
Pei, Renzhi;
Jin, Jie

Publication type:

journal article

Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes.

Published in:

Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 845, doi. 10.1007/s00432-021-03905-y

By:

Jiang, Lingxu;
Ye, Li;
Ma, Liya;
Ren, Yanling;
Zhou, Xinping;
Mei, Chen;
Xu, Gaixiang;
Yang, Haiyang;
Lu, Chenxi;
Luo, Yingwan;
Zhu, Shuanghong;
Wang, Lu;
Shen, Chuying;
Yang, Wenli;
Zhang, Qi;
Wang, Yuxia;
Lang, Wei;
Han, Yueyuan;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.

Published in:

Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1037, doi. 10.1007/s00432-018-2627-3

By:

Lin, Peipei;
Luo, Yingwan;
Zhu, Shuanghong;
Maggio, Dominic;
Yang, Haiyang;
Hu, Chao;
Wang, Jinghan;
Zhang, Hua;
Ren, Yanling;
Zhou, Xinping;
Mei, Chen;
Ma, Liya;
Xu, Weilai;
Ye, Li;
Zhuang, Zhengping;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acid.

Published in:

Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2430044

By:

Zhu, Li;
Shi, Ting;
Liu, Yi;
Zhao, Shuqi;
Wang, Huanping;
Chen, Zhimei;
Wang, Yungui;
Jin, Jie;
Tong, Hongyan;
You, Liangshun;
Zhu, Hong-Hu

Publication type:

Article

Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21).

Published in:

Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2023.2293513

By:

Liu, Lin;
Wang, Jinghan;
Xu, Huan;
Zhao, Shuqi;
Wang, Lu;
Huang, Jiansong;
Wang, Huanping;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Case Report: Pathogenesis With a Rare RHOA A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma.

Published in:

Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.948744

By:

Lihong Cao;
Hongyan Tong;
Xing Liu;
Yingqing Xu;
Fang Yu;
Qi Pan;
Jin Lai;
Jian Huang;
Jiayue Qin;
Jie Jin

Publication type:

Article

Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Frontiers of Medicine, 2017, v. 11, n. 2, p. 229, doi. 10.1007/s11684-017-0506-y

By:

Lou, Yinjun;
Ma, Yafang;
Li, Chenyin;
Suo, Sansan;
Tong, Hongyan;
Qian, Wenbin;
Mai, Wenyuan;
Meng, Haitao;
Yu, Wenjuan;
Mao, Liping;
Wei, Juyin;
Xu, Weilei;
Jin, Jie

Publication type:

Article

Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Published in:

Frontiers of Medicine, 2017, v. 11, n. 2, p. 287, doi. 10.1007/s11684-017-0510-2

By:

Zhou, Xinping;
Wei, Juying;
Lou, Yinjun;
Xu, Gaixiang;
Yang, Min;
Liu, Hui;
Mao, Liping;
Tong, Hongyan;
Jin, Jie

Publication type:

Article

Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.

Published in:

Frontiers of Medicine, 2016, v. 10, n. 4, p. 430, doi. 10.1007/s11684-016-0492-5

By:

Zhou, Xinping;
Ye, Xingnong;
Ren, Yanling;
Mei, Chen;
Ma, Liya;
Huang, Jiansong;
Xu, Weilai;
Wei, Juying;
Ye, Li;
Mai, Wenyuan;
Qian, Wenbin;
Meng, Haitao;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Advances in biology, diagnosis and treatment of DLBCL.

Published in:

Annals of Hematology, 2024, v. 103, n. 9, p. 3315, doi. 10.1007/s00277-024-05880-z

By:

Shi, Yuanfei;
Xu, Yi;
Shen, Huafei;
Jin, Jie;
Tong, Hongyan;
Xie, Wanzhuo

Publication type:

Article

Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm.

Published in:

Annals of Hematology, 2024, v. 103, n. 6, p. 2165, doi. 10.1007/s00277-024-05749-1

By:

Huang, Xianbo;
Wang, Shasha;
Xu, Yu;
Mei, Chen;
Han, Qingmei;
Wu, Xianhui;
Du, Fengwei;
Ren, Yanling;
Jin, Jie;
Tong, Hongyan;
Qian, Jiejing

Publication type:

Article